어셔 증후군 시장 점유율, 규모, 동향, 산업 분석 보고서 : 질병 유형별, 치료별, 최종사용자별, 지역별, 부문별 예측(2024-2032년)

The global Usher syndrome market size is expected to reach USD 3.08 billion by 2032, according to a new study by Polaris Market Research. The report "Usher syndrome Share, Size, Trends, Industry Analysis Report, By Disease Type (Type1, Type2, Type3); By Treatment; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Usher syndrome is a genetic disorder that affects both hearing and vision loss. The hearing loss can be mild to moderate, whereas the patient's vision is slowly damaged over time. In a few cases, the patient also experiences trouble while balancing their body. According to the data published by the National Center for Biotechnology Information, it was estimated that around 400,000 people suffer from this syndrome worldwide.

The rising prevalence of genetic and inherited diseases worldwide propels this market's expansion. Also, an increase in investment by players in R&D activities for genetic disorders like Usher syndrome is expected to boost the market growth in the forecast period. Advancements in minimally invasive surgeries and devices such as cochlear implants and hearing devices that can improve hearing are anticipated to impact the growth positively. However, lack of awareness among the general population, delay in diagnosis, and limited availability of treatment options are some of the major factors hindering the growth of the Usher syndrome market.

Throughout the forecast period, the progression of groundbreaking therapeutics is expected to influence market share and is predominantly dependent on ongoing clinical trials and regulatory approvals. The essential role of clinical studies in assessing the safety and efficacy of innovative Usher syndrome therapeutic approaches, including medications, medical devices, gene therapies, and other interventions, must be addressed. The increase in the number of clinical trials signifies a growing interest of market players in addressing Usher syndrome as more research and development efforts are directed toward discovering effective treatments for the disease.

Government bodies and various organizations are taking initiatives regarding the consciousness of the disease, showing alteration in the market in upcoming years. The primary objective of this healthcare initiative is to spread awareness about the disease globally. Consequently, such global initiatives are anticipated to enhance public awareness, due to an upsurge in the diagnosis and treatment rates of Usher syndrome, which drive the market.

Usher Syndrome Market Report Highlights

In 2023, the hearing aid device held the largest revenue share; these are a common and effective solution for managing hearing impairment, making them a crucial component of treatment for individuals with Usher syndrome.

The hospital segment is anticipated to witness the fastest CAGR during the forecast period due to specialized departments and expertise in diagnosing and treating rare genetic conditions, including Usher syndrome. The availability of specialized healthcare professionals, genetic counselors, and advanced diagnostic equipment in hospitals may contribute to increased patient visits.

In 2023, North America accounted for the largest market due to the high prevalence of Usher syndrome, which drives the demand for treatment options, including hearing devices and other therapies. Moreover, the region has a strong direct presence of market players and a well-established healthcare infrastructure, allowing for the widespread adoption and utilization of medical devices and services.

The global key market players include Johnson & Johnson Services, Inc., Amgen Inc., Cochlear Ltd, Sonova, Audina Hearing Instruments Inc., Nurotron Biotechnology Co. Ltd., and others.

Polaris Market Research has segmented the Usher syndrome market report based on disease type, treatment, end-use, and region:

Usher Syndrome, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Type1
• Type2
• Type3

Usher Syndrome, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)

• Devices
• Hearing Aids
• Cochlear implants
• Vision aids
• Therapy
• Occupational therapy
• Speech therapy
• Physical therapy
• Drugs
• Vitamin A supplement
• Others

Usher Syndrome, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

• Hospitals
• ENT clinics
• Ophthalmic clinics
• Others

Usher Syndrome, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Usher Syndrome Market Insights

• 4.1. Usher Syndrome Market - End Use Snapshot
• 4.2. Usher Syndrome Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Prevalence of Deafness or Hearing Loss
    • 4.2.1.2. Rapid Pharmaceutical Advancements and Clinical Research
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Fewer Information Accessible for The Reference
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Usher Syndrome Market End Use Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Usher Syndrome Market, by Disease Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
• 5.3. Type 1
  • 5.3.1. Global Usher Syndrome Market, by Type 1, by Region, 2019-2032 (USD Billion)
• 5.4. Type 2
  • 5.4.1. Global Usher Syndrome Market, by Type 2, by Region, 2019-2032 (USD Billion)
• 5.5. Type 3
  • 5.5.1. Global Usher Syndrome Market, by Type 3, by Region, 2019-2032 (USD Billion)

6. Global Usher Syndrome Market, by Treatment

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
• 6.3. Device
  • 6.3.1. Global Usher Syndrome Market, by Device, by Region, 2019-2032 (USD Billion)
  • 6.3.2. Hearing Aid
    • 6.3.2.1. Global Usher Syndrome Market, by Hearing Aid, by Region, 2019-2032 (USD Billion)
  • 6.3.3. Cochlear Implants
    • 6.3.3.1. Global Usher Syndrome Market, by Cochlear Implants, by Region, 2019-2032 (USD Billion)
  • 6.3.4. Vision Aids
    • 6.3.4.1. Global Usher Syndrome Market, by Vision Aids, by Region, 2019-2032 (USD Billion)
• 6.4. Therapy
  • 6.4.1. Global Usher Syndrome Market, by Therapy, by Region, 2019-2032 (USD Billion)
  • 6.4.2. Speech Therapy
    • 6.4.2.1. Global Usher Syndrome Market, by Speech Therapy, by Region, 2019-2032 (USD Billion)
  • 6.4.3. Physical Therapy
    • 6.4.3.1. Global Usher Syndrome Market, by Physical Therapy, by Region, 2019-2032 (USD Billion)
  • 6.4.4. Occupational Therapy
    • 6.4.4.1. Global Usher Syndrome Market, by Occupational Therapy, by Region, 2019-2032 (USD Billion)
• 6.5. Drugs
  • 6.5.1. Global Usher Syndrome Market, by Drugs, by Region, 2019-2032 (USD Billion)
  • 6.5.2. Vitamin A
    • 6.5.2.1. Global Usher Syndrome Market, by Vitamin A , by Region, 2019-2032 (USD Billion)
  • 6.5.3. Others
    • 6.5.3.1. Global Usher Syndrome Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Usher Syndrome Market, by End Use

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
• 7.3. Hospital
  • 7.3.1. Global Usher Syndrome Market, by Hospital, By Region, 2019-2032 (USD Billion)
• 7.4. Ophthalmic Care
  • 7.4.1. Global Usher Syndrome Market, by Ophthalmic Care, By Region, 2019-2032 (USD Billion)
• 7.5. ENT Clinics
  • 7.5.1. Global Usher Syndrome Market, by ENT Clinics, By Region, 2019-2032 (USD Billion)
• 7.6. Others
  • 7.6.1. Global Usher Syndrome Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Usher Syndrome Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Usher Syndrome Market Assessment, By Geography, 2019-2032 (USD Billion)
• 8.3. Usher Syndrome Market - North America
  • 8.3.1. North America: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.3.2. North America: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
  • 8.3.3. North America: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.3.4. Usher Syndrome Market - U.S.
    • 8.3.4.1. U.S.: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.3.4.2. U.S.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.4.3. U.S.: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.3.5. Usher Syndrome Market - Canada
    • 8.3.5.1. Canada: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.3.5.2. Canada.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.5.3. Canada: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
• 8.4. Usher Syndrome Market - Europe
  • 8.4.1. Europe: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.4.2. Europe.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
  • 8.4.3. Europe: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.4. Usher Syndrome Market - UK
    • 8.4.4.1. UK: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.4.2. UK.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.4.3. UK: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.5. Usher Syndrome Market - France
    • 8.4.5.1. France: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.5.2. France.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.5.3. France: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.6. Usher Syndrome Market - Germany
    • 8.4.6.1. Germany: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.6.2. Germany.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.6.3. Germany: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.7. Usher Syndrome Market - Italy
    • 8.4.7.1. Italy: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.7.2. Italy.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.7.3. Italy: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.8. Usher Syndrome Market - Spain
    • 8.4.8.1. Spain: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.8.2. Spain.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.8.3. Spain: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.9. Usher Syndrome Market - Netherlands
    • 8.4.9.1. Netherlands: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.9.2. Netherlands.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.9.3. Netherlands: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.4.10. Usher Syndrome Market - Russia
    • 8.4.10.1. Russia: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.10.2. Russia.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.10.3. Russia: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
• 8.5. Usher Syndrome Market - Asia Pacific
  • 8.5.1. Asia Pacific: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.5.2. Asia Pacific.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
  • 8.5.3. Asia Pacific: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.5.4. Usher Syndrome Market - China
    • 8.5.4.1. China: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.4.2. China.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.4.3. China: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.5.5. Usher Syndrome Market - India
    • 8.5.5.1. India: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.5.2. India.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.5.3. India: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.5.6. Usher Syndrome Market - Malaysia
    • 8.5.6.1. Malaysia: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.6.2. Malaysia.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.6.3. Malaysia: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.5.7. Usher Syndrome Market - Japan
    • 8.5.7.1. Japan: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.7.2. Japan.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.7.3. Japan: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.5.8. Usher Syndrome Market - Indonesia
    • 8.5.8.1. Indonesia: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.8.2. Indonesia.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.8.3. Indonesia: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.5.9. Usher Syndrome Market - South Korea
    • 8.5.9.1. South Korea: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.9.2. South Korea.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.9.3. South Korea: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
• 8.6. Usher Syndrome Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.6.2. Middle East & Africa.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
  • 8.6.3. Middle East & Africa: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.6.4. Usher Syndrome Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.4.2. Saudi Arabia.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.6.5. Usher Syndrome Market - UAE
    • 8.6.5.1. UAE: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.5.2. UAE.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.5.3. UAE: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.6.6. Usher Syndrome Market - Israel
    • 8.6.6.1. Israel: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.6.2. Israel.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.6.3. Israel: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.6.7. Usher Syndrome Market - South Africa
    • 8.6.7.1. South Africa: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.7.2. South Africa.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.7.3. South Africa: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
• 8.7. Usher Syndrome Market - Latin America
  • 8.7.1. Latin America: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.7.2. Latin America.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
  • 8.7.3. Latin America: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.7.4. Usher Syndrome Market - Mexico
    • 8.7.4.1. Mexico: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.7.4.2. Mexico.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.4.3. Mexico: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.7.5. Usher Syndrome Market - Brazil
    • 8.7.5.1. Brazil: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.7.5.2. Brazil.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.5.3. Brazil: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)
  • 8.7.6. Usher Syndrome Market - Argentina
    • 8.7.6.1. Argentina: Usher Syndrome Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.7.6.2. Argentina.: Usher Syndrome Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.6.3. Argentina: Usher Syndrome Market, by Treatment, 2019-2032 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Audina
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Cochlear Ltd
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Earsmate
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Enhanced Vision
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. Hearing Instruments, Inc.
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Johnson and Johnson service Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Med-El
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. Nurotron Biotechnology Co. Ltd
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Ototronix Diagnostics
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Rion Co. Ltd
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. Sonova
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Tobii Dynavox Us
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development